Yao H W, Wu H W, Liu Y H
*Department of Gastrointestinal Surgery, Branch Center of General Surgery, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing 100050, China.
Zhonghua Wai Ke Za Zhi. 2017 Jan 1;55(1):24-27. doi: 10.3760/cma.j.issn.0529-5815.2017.01.007.
The eighth edition of cancer staging system published by AJCC will be implemented all over the world in January 1, 2018. In addition to strengthening the traditional TNM staging system, the introduction of new molecular markers, is a major advance in the eighth edition, and is expected to play a more valuable role in the"individualized" clinical practice. The most important update in the eighth edition of AJCC colorectal cancer staging system is"non-anatomic" prognostic and predictive evaluation system based on the molecular detection. The system is useful for better understanding the pathogenesis of colorectal cancer, and guide clinicians to provide individualized treatment for the patients even in the same stage of colorectal cancer.
美国癌症联合委员会(AJCC)发布的癌症分期系统第八版将于2018年1月1日在全球实施。除了强化传统的TNM分期系统外,引入新的分子标志物是第八版的一项重大进展,预计将在“个体化”临床实践中发挥更有价值的作用。AJCC结直肠癌分期系统第八版最重要的更新是基于分子检测的“非解剖学”预后和预测评估系统。该系统有助于更好地理解结直肠癌的发病机制,并指导临床医生即使在结直肠癌处于同一阶段时也能为患者提供个体化治疗。